Attenuation of alcohol consumption by a novel nontoxic ibogaine analogue (18-methoxycoronaridine) in alcohol-preferring rats

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 2, 1997, Pages 615-619

  Rezvani, Amir H ^a   Overstreet, David H ^a   Yang, Ying ^a   Maisonneuve, Isabelle M ^b   Bandarage, Upul K ^c   Kuehne, Martin E ^c   Glick, Stanley D ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF VERMONT   (United States)

Author keywords

Alcohol drinking; Drug abuse; Ibogaine; Ibogaine analogue; Pharmacotherapy

Indexed keywords

ALKALOID;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRINKING BEHAVIOR; DRUG ABUSE; FLUID INTAKE; FOOD INTAKE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030830104     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)10003-X     Document Type: Article

References (42)

1. Borg V. Bromocriptine in the prevention of alcohol abuse. Acta Psychiatr. Scand. 68:1983;100-110.
2. 3H]GBR-1235 binding to the dopamine transporter protein. NIDA Res. Monogr. Ser. 119:1992;285.
3. Cappendijk S. L. T., Dzoljic M. R. Inhibitory effects of Ibogaine on cocaine self-administration in rats. Eur. J. Pharmacol. 241:1993;261-265.
4. DiChiara G., Imperato A. Ethanol preferentially stimulates dopamine release in the nucleus accumbens of freely moving rats. Eur. J. Pharmacol. 115:1985;131-132.
5. Froehlich J. C. Harts, J.; Lumeng, L.; Li, T.-K. Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference Pharmacol. Biochem. Behav. 35:1990;385-390.
6. Gatto G. J., McBride W. J., Murphy J. M., Lumeng L., Li T. K. Ethanol self-infusion into the ventral tegmental area by alcohol-preferring rats. Alcohol. 11:1994;557-564.
7. Gessa G. L., Muntoni F., Collu M., Vargin L., Mereu G. Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res. 348:1985;201-203.
8. Glick S. D., Kuehne M. E., Maisonneuve I. M., Bandarage U. K., Molinari H. H. 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener. Effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats Brain Res. 719:1996;29-35.
9. Glick S. D., Kuehne M. E., Raucci J., Wilson T. E., Larson T. D., Keller R. W., Carlson J. N. Effects of iboga alkaloids on morphine and cocaine self-administration in rats. Relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum Brain Res. 657:1994;14-22.
10. Glick S. D., Rossman K., Steindorf S., Maisonneuve I. M., Carlson J. N. Effects and after effects of Ibogaine on morphine self-administration in rats. Eur. J. Pharmacol. 195:1991;341.
11. Glick S. D., Rossman K., Wang S., Dong N., Keller R. W. Jr. Local effects of Ibogaine on extracellular levels of dopamine and its metabolites in nucleus accumbens and striatum. Interactions with d-amphetamine Brain Res. 628:1993;201-208.
12. Koob G. F., Rassnick S., Heinrichs S., Weiss F. Alcohol, the reward system and dependence. EXS. 71:1994;103-104.
13. Maisonneuve I. M., Keller R. W., Glick S. D. Interactions between ibogaine, a potential anti-addictive agent, and morphine. An in vivo microdialysis study Eur. J. Pharmacol. 199:1991;35-42.
14. Maisonneuve I. M., Rossman K. L., Keller R. W. Jr., Glick S. D. Acute and prolonged effects of Ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats. Brain Res. 575:1992;69-73.
15. Mash D. C., Staley J. K., Pablo J. P., Holohean A. M., Hackman J. C., Davidoff R. A. Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex. Neurosci. Lett. 192:1995;53-56.
16. Mash D. C., Staley J. K., Bauman M. H., Rothman R. B., Hearn W. L. Identification of primary metabolite of ibogaine that targets serotonin transporters and elevated serotonin. Life Sci. 57:1995;Pl45-Pl50.
17. Mason G. A., Rezvani A. H., Overstreet D. H., Garbutt J. C. The thyrotropin releasing hormone analog TA-0910 reduces voluntary alcohol intake of P rats subchronically in a limited scheduled access paradigm. Alcohol Clin. Exp. Res. 20:1996;1000-1003.
18. Mason G. A., Rezvani A. H., Grady D. R., Garbutt J. C. The sub-chronic effects of the TRH analog TA-0910 and bromocriptine on alcohol preference in alcohol preferring (P) rats. Development of tolerance and cross tolerance Alcohol Clin. Exp. Res. 18:1994;1196-1201.
19. McBride W. J., Murphy J. M., Lumeng L., Li T.-K. Serotonin, dopamine and GABA involvement in alcohol drinking of selectively bred rats. Alcohol. 7:1990;199-205.
20. Molinari, H. H.; Maisonneuve, I. M.; Glick S. D.: Ibogaine neurotoxicity: A reevaluation. Brain Res.; in press.
21. Murphy J. M., McBride W. J., Lumeng L., Li T.-K. Effects of serotonin and dopamine agents on ethanol intake of alcohol-preferring (P) rats. Alcohol Clin. Exp. Res. 12:1988;306.
22. O'Hearn E., Molliver M. E. Degeneration of Purkinje cells in parasagital zones of the cerebellar vermis after ibogaine or harmaline. Neuroscience. 55:1993;303-310.
23. Overstreet D. H., Rezvani A. H., Pucilowski O., Janowsky D. S. 5-HT receptors. Implications for the neuropharmacology of alcohol and alcoholism Alcohol Alcohol. suppl. 2:1994;207-212.
24. Overstreet D. H., Lee Y. W., Rezvani A. H. Suppression of alcohol intake after administration of the Chinese herbal medicinein, NPI-028, and its derivatives. Alcohol Clin. Exp. Res. 20:1996;221-227.
25. Overstreet D. H., Rezvani A. H., Janowsky D. S. Genetic animal models of depression and ethanol preference provide support for cholinergic and serotonergic involvement in depression and alcoholism. Biol. Psychiatr. 31:1992;919-936.
26. Popik P., Layer R. T., Skolnick P. 100 Years of ibogaine. Neurochemical and pharmacological actions of a putative anti-addictive drug Pharmacol. Rev. 47:1995;235-253.
27. Pucilowski O., Rezvani A. H., Overstreet D. H., Janowsky D. S. Calcium channel inhibitors attenuate consumption of ethanol, sucrose and saccharin solutions in rats. Behav. Pharmacol. 5:1994;494-501.
28. Reid L. D., Delconte J. D., Nichols M. L., Bilsky E. J., Hubbell C. L. Tests of opioid deficiency hypotheses of alcoholism. Alcohol. 8:1991;247-257.
29. Rezvani A. H., Garbutt J. C., Overstreet D. H., Li L., Walker C. H., Mason G. A. Thyrotropin releasing hormone analog TA-0910 suppresses alcohol intake in alcohol drinking African green monkeys. Alcohol Clin. Exp. Res. 21:1997;261-266.
30. Rezvani A. H., Grady D. R. Suppression of alcohol consumption by fenfluramine in Fawn-Hooded rats with serotonin dysfunction. Pharmacol. Biochem. Behav. 48:1994;105-110.
31. Rezvani A. H., Mash D. C., Hearn W. L., Lee Y. W., Overstreet D. H. Noribogaine, a primary ibogaine metabolite, reduces alcohol intake in P and Fawn-Hooded rats. Alcohol Clin. Exp. Res. 19:1995;15A.
32. Rezvani A. H., Overstreet D. H., Janowsky D. S. Drug-induced reductions in ethanol intake in alcohol preferring and fawn-hooded rats. Alcohol Alcohol. suppl. 1:1991;433-437.
33. Rezvani A. H., Overstreet D. H., Janowsky D. S. Genetic serotonin deficiency and alcohol preference in the Fawn-Hooded rats. Alcohol Alcohol. 25:1990;573-575.
34. Rezvani A. H., Garbutt J. C., Shimoda K., Garges P. L., Janowsky D. S., Mason G. A. Attenuation of alcohol preference in alcohol preferring rats by a novel TRH analogue TA-0910. Alcohol Clin. Exp. Res. 16:1992;326-330.
35. Rezvani A. H., Garges P. L., Miller D., Gordon C. J. Attenuation of alcohol consumption by MDMA in two strains of alcohol drinking rats. Pharmacol. Biochem. Behav. 43:1992;103-107.
36. Rezvani A. H., Overstreet D. H., Lee Y. W. Attenuation of alcohol intake by Ibogaine in three starins of alcohol preferring rats. Pharmacol. Biochem. Behav. 52:1995;615-620.
37. Samson H. H., Tolliver G. A., Haraguchi M., Hodge C. W. Alcohol self-administration. Role of mesolimbic dopamine Ann. N.Y. Acad. Sci. 654:1992;242-253.
38. Sellers E. M., Higgins G. A., Sobell M. B. 5-HT and alcohol abuse. Trends Pharmacol. Sci. 13:1992;69-75.
39. Sershen H., Harsing L. G. Jr., Hashim A., Lajtha A. Ibogaine reduces amphetamine-induced locomotor stimulation in C57BL/6By mice, but stimulates locomotor activity in rats. Life Sci. 51:1992;1003-1011.
40. Sershen H., Hashim A., Lajtha A. Effect of Ibogaine on serotonergic and dopaminergic interactions in striatum from mice and rats. Neurochem. Res. 19:1994;1463-1466.
41. Sershen H., Hashim A., Lajtha A. Ibogaine reduces preference for cocaine consumption in C57BL/6By mice. Pharmacol. Biochem. Behav. 47:1994;13-19.
42. Volpicelli J. R., Alterman A. I., Hayashida M., O'Brien C. P. Naltrexone in the treatment of alcohol dependence. Arch. Gen. Psychiatr. 49:1992;876-880.